Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.

By Holst J.   Lindblad B.   Bergqvist D.   Hedner U.   Nordfang O.   Ostergaard P.  

Thrombosis Research, Vol. 86, Iss. 4, 1997-05 ,pp. : 343-348

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

Brief communication effect of protamine on heparin releasable TFPI antigen levels in normal volunteers

By Hoppensteadt D.A.   Fasanella A.   Fareed J.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 325-330

Elsevier

Access to resources Recommend Favorite

The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells - Identification by morphological and immunological criteria

By Young E.   Venner T.   Ribau J.   Shaughnessy S.   Hirsh J.   Podor T.J.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 373-381

Elsevier

Access to resources Recommend Favorite